Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biogen Inc (NASDAQ:BIIB)

286.72
Delayed Data
As of Aug 22
 +3.57 / +1.26%
Today’s Change
244.28
Today|||52-Week Range
303.81
+9.77%
Year-to-Date

Today’s Trading

Previous close283.15
Today’s open284.13
Day’s range283.11 - 288.15
Volume944,995
Average volume (3 months)1,454,282
Market cap$60.6B
Dividend yield--
Data as of 08/22/2017

Growth & Valuation

Earnings growth (last year)+10.32%
Earnings growth (this year)+5.78%
Earnings growth (next 5 years)+6.60%
Revenue growth (last year)+9.37%
P/E ratio18.8
Price/Sales6.09
Price/Book5.10

Competitors

 Today’s
change
Today’s
% change
ILMNIllumina Inc+4.08+2.14%
GILDGilead Sciences+0.74+1.02%
KITEKite Pharma Inc+2.04+1.52%
BIVVBioverativ Inc+1.56+2.85%
Data as of 08/22/2017

Financials

Next reporting dateOctober 25, 2017
EPS forecast (this quarter)$5.62
Annual revenue (last year)$10.2B
Annual profit (last year)$3.7B
Net profit margin36.32%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Michel Vounatsos
Senior Vice President-
US Therapeutic Operations
Alisha A. Alaimo
Corporate headquarters
Cambridge, Massachusetts

Forecasts